GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Net Interest Income (for Banks)

Toleranzia AB (OSTO:TOL) Net Interest Income (for Banks)


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Toleranzia AB (OSTO:TOL) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.